Related references
Note: Only part of the references are listed.Prognostic indicators in WHO 2003 low-grade endometrial stromal sarcoma
Weiwei Feng et al.
HISTOPATHOLOGY (2013)
YWHAE-FAM22 endometrial stromal sarcoma: diagnosis by reverse transcription-polymerase chain reaction in formalin-fixed, paraffin-embedded tumor
Anna Isphording et al.
HUMAN PATHOLOGY (2013)
Stages I to II WHO 2003-Defined Low-Grade Endometrial Stromal Sarcoma How Much Primary Therapy Is Needed and How Little Is Enough?
Weiwei Feng et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2013)
Prognostic Value of the Diagnostic Criteria Distinguishing Endometrial Stromal Sarcoma, Low Grade From Undifferentiated Endometrial Sarcoma, 2 Entities Within the Invasive Endometrial Stromal Neoplasia Family
Weiwei Feng et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2013)
Can Proliferation Biomarkers Reliably Predict Recurrence in World Health Organization 2003 Defined Endometrial Stromal Sarcoma, Low Grade?
Weiwei Feng et al.
PLOS ONE (2013)
The Clinicopathologic Features of YWHAE-FAM22 Endometrial Stromal Sarcomas: A Histologically High-grade and Clinically Aggressive Tumor
Cheng-Han Lee et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
Cyclin D1 as a Diagnostic Immunomarker for Endometrial Stromal Sarcoma With YWHAE-FAM22 Rearrangement
Cheng-Han Lee et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
14-3-3 fusion oncogenes in high-grade endometrial stromal sarcoma
Cheng-Han Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Cyclin D as a therapeutic target in cancer
Elizabeth A. Musgrove et al.
NATURE REVIEWS CANCER (2011)
Endometrial Stromal Sarcomas A Review of Potential Prognostic Factors
Ivy Chew et al.
ADVANCES IN ANATOMIC PATHOLOGY (2010)
Transition From Low-grade Endometrial Stromal Sarcoma to High-grade Endometrial Stromal Sarcoma
Yoshiki Ohta et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2010)
Coincident expression of β-catenin and cyclin D1 in endometrial stromal tumors and related high-grade sarcomas
Shuichi Kurihara et al.
MODERN PATHOLOGY (2010)
Towards a knowledge-based Human Protein Atlas
Mathias Uhlen et al.
NATURE BIOTECHNOLOGY (2010)
Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients
Vera M. Abeler et al.
HISTOPATHOLOGY (2009)
Comparative clinicopathologic and immunohistochemical analysis of uterine sarcomas diagnosed using the World Health Organization classification system
Emanuela D'Angelo et al.
HUMAN PATHOLOGY (2009)
Cell cycle kinases as therapeutic targets for cancer
Silvia Lapenna et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro
Richard S. Finn et al.
BREAST CANCER RESEARCH (2009)
Endometrial stromal sarcomas and related high-grade sarcomas: Immunohistochemical and molecular genetic study of 31 cases
Shuichi Kurihara et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
Endometrial stromal sarcoma: a population-based analysis
J. K. Chan et al.
BRITISH JOURNAL OF CANCER (2008)
A multi-institutional review of outcomes of endometrial stromal sarcoma
Charles A. Leath et al.
GYNECOLOGIC ONCOLOGY (2007)
Prognostic factors and outcome in women with uterine sarcoma
D. Denschlag et al.
EJSO (2007)
Endometrial stromal tumours of the uterus: a practical approach using conventional morphology and ancillary techniques
Patricia Baker et al.
JOURNAL OF CLINICAL PATHOLOGY (2007)
Molecular analysis of the JAZF1-JJAZ1 gene fusion by RT-PCR and fluorescence in situ hybridization in endometrial stromal neoplasms
Marisa R. Nucci et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2007)
Transition of endometrial stromal sarcoma into high-grade sarcoma
Frederic Amant et al.
GYNECOLOGIC ONCOLOGY (2006)
In vitro and in vivo activity of R547:: a potent and selective cyclin-dependent kinase inhibitor currently in phase I clinical trials
Wanda DePinto et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Consistent rearrangement of chromosomal band 6p21 with generation of fusion genes JAZF1/PHF1 and EPC1/PHF1 in endometrial stromal sarcoma
F Micci et al.
CANCER RESEARCH (2006)
ANLN plays a critical role in human lung carcinogenesis through the activation of RHOA and by involvement in the phosphoinositide 3-kinase/AKT pathway
C Suzuki et al.
CANCER RESEARCH (2005)
JAZF1/JJAZ1 gene fusion in endometrial stromal sarcomas -: Molecular analysis by reverse transcriptase-polymerase chain reaction optimized for paraffin-embedded tissue
A Hrzenjak et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2005)
Chromosomal alterations in low-grade endometrial stromal sarcoma and undifferentiated endometrial sarcoma as detected by comparative genomic hybridization
I Halbwedl et al.
GYNECOLOGIC ONCOLOGY (2005)
Molecular detection of JAZF1-JJAZ1 gene fusion in endometrial stromal neoplasms with classic and variant histology -: Evidence for genetic heterogeneity
HY Huang et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2004)
Inverse correlation of secreted frizzled-related protein 4 and β-catenin expression in endometrial stromal sarcomas
A Hrzenjak et al.
JOURNAL OF PATHOLOGY (2004)
Cytogenetic and molecular genetic analyses of endometrial stromal sarcoma:: nonrandom involvement of chromosome arms 6p and 7p and confirmation of JAZF1/JJAZ1 gene fusion in t(7;17)
F Micci et al.
CANCER GENETICS AND CYTOGENETICS (2003)
Long-term survival of patients given hormonal therapy for metastatic endometrial stromal sarcoma
JP Spano et al.
MEDICAL ONCOLOGY (2003)
Frequent fusion of the JAZF1 and JJAZ1 genes in endometrial stromal tumors
JI Koontz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Prognostic parameters in endometrial stromal sarcoma: A clinicopathologic study in 31 patients
K Bodner et al.
GYNECOLOGIC ONCOLOGY (2001)
Share Paper
